An underground market for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.
Investigational Drug Acquiring Traction Via Social Media
Retatrutide, which is still in research studies, is being promoted by social media influencers for its supposed fat-burning effects. Viewers are encouraged to message these profiles privately for source information, while also obtaining promotional offers.
Active Commerce on Messaging Platforms
Separately, a flourishing trade exists on Telegram, where communities with thousands of participants share “before and after” photos, administration instructions and assertions of rapid UK delivery. Sellers market the drug there before directing customers to WhatsApp for transactions.
Understanding The Experimental Drug
Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could help patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.
Healthcare Experts Voice Concerns
However, doctors and pharmacists have warned that the distribution of what is still an unlicensed medication in the UK is a cause for concern and could lead to individuals injecting products of uncertain source.
Several experts stated the demand for the experimental drug could be linked to the rising cost of licensed weight loss products such as Mounjaro.
Regulatory Position and Implementation
Marketing retatrutide on social media or Telegram is prohibited in the UK, as it is an unlicensed drug that cannot be promoted or distributed for human use under the British medical regulations.
Some influencers try to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still violate pharmaceutical, marketing, and consumer regulations, potentially leading to penalties, legal action or prison.
Service Reaction and Material Removal
Based on the social media company, the service has removed problematic material and banned associated keywords and search suggestions. The organization said it was committed to maintaining the service safe and allocating resources in strengthening enforcement strategies.
Online Marketplace Operations
Research also found communities with up to 9,000 participants marketing retatrutide using Telegram's integrated discovery tool, which functions like a online catalog. Typing “retatrutide” instantly displays channels with thousands of users, filled with images of slimming results, positive reviews and step-by-step guides for mixing or administering at residence.
Within minutes of entering one community, a seller shared contact information, where the majority of purchases occur. The vendor provided an guidebook and guaranteed shipping within 48 hours. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None inquired about body mass, health issues or past usage.
Product Information and Pricing
Within these communities, posts show dark colored parcels with postal service stickers, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, mixed at home with purified liquid, or pre-filled pens typically sold at £160 for 20mg. When asked how long a injector should last, vendors give contradictory responses ranging from a few weeks to “depends on your body”.
Platform Oversight and Security Measures
A spokesperson for Telegram said it regularly moderated harmful material on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“Individuals are administering substances they cannot confirm. Although the science behind this drug is valid, these digital versions may not include what they claim,” stated a pharmacy expert, the head of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor connected the surge in demand to current price rises for approved weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But counterfeit treatments are highly risky. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she said.
Her staff has already seen patients harmed by self-injection from unverified suppliers. “We understand the disappointment, but buying from Telegram or WhatsApp is taking chances with your well-being,” said the doctor. “These materials could be impure or incorrectly dosed.”
Producer Statement
A representative from the pharmaceutical company stated retatrutide was in third stage research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they said, noting that any item “falsely representing itself as a company experimental product not yet authorized … may subject users to potentially significant health risks”.
